Search

  • Search


    Provision of fluorescently labelled probes for the Fluorescent in situ Hybridisation (FISH) Service in the Histopathology Dept at St James’s Hospital.

    St James's Hospital

    Provision of fluorescently labelled probes for the Fluorescent in situ Hybridisation (FISH) Service in the Histopathology Dept at St James’s Hospital.

    1. Competition notice published

      Feb 13, 8:29 AMFebruary 13, 2026 8:29 AM
    2. Contract signed

      Jul 1, 12:00 AMJuly 1, 2026 12:00 AM
    3. Result notice published

      Jul 1, 12:30 PMJuly 1, 2026 12:30 PM

    Brief

    Ireland: Tenders/St James's Hospital/Provision of fluorescently labelled probes for the Fluorescent in situ Hybridisation (FISH) Service in the Histopathology Dept at St James’s Hospital.

    Awarded

    The competition has ended and a winner has been selected.

    Brief

    Laboratorie- og analyseutstyr

    St James's Hospital has entered into an agreement with Clinisciences Limited for the provision of fluorescently labelled probes for the Fluorescent in situ Hybridisation (FISH) Service in the Histopathology Department. The services will be delivered in Ireland over a period of 60 months, with a total value of 764,481 EUR. The probes are required to be IVDR-certified and suitable for use on formalin-fixed, paraffin-embedded specimens in a ready-to-use format, ensuring reliable and reproducible results, long-term serviceability, and user training. Two bids were received for this contract.

    Result

    Winner
    Clinisciences Limited
    Number of bids
    2
    Contract value
    €764,481

    About the bid

      Invitation to tender for the Provision of fluorescently labelled probes for the Fluorescent in situ Hybrisisation (FISH) Service in the Histopathology Dept at St James’s Hospital. The FISH service at SJH has provided a hospital and national service since 2010, helping on cancer classification and to guide patient treatment. The laboratory now requires the provision of the following fluorescently labelled ready to use probes: • MYC (8q24) Break Apart FISH probe, to detect chromosomal rearrangements involving the MYC gene on Chromosome 8q24. • t(8;14) MYC/IGH dual-fusion FISH probe, to detect reciprocal translocation involving the IGH and MYC genes. • BCL2 (18q21) Break Apart FISH probe, to detect chromosomal rearrangements involving the BCL2 gene on Chromosome 18q21. • t(14;18) IGH/BCL2 DF dual-fusion FISH probe, to detect reciprocal translocations involving the IGH and BCL2 genes. • BCL6 (3q27) Break Apart FISH probe, to detect chromosomal rearrangements involving the BCL6 gene on Chromosome 3q27. • MALT1 (18q21) Break Apart FISH probe, to detect chromosomal rearrangements involving the MALT1 gene on Chromosome 18q21. • t(11;14) CCDN1/IGH dual-fusion FISH probe, to detect reciprocal translocations involving the IGH and CCDN1 genes. • IgK-cMYC dual-fusion FISH probe, to detect reciprocal translocation involving the IGK and MYC genes. • IgL-cMYC dual-fusion FISH probe, to detect reciprocal translocation involving the IGL and MYC genes. • DUSP22-IRF4 Break Apart FISH probe, to detect chromosomal rearrangements involving the DUSP22 or IRF4 gene. • TP63 Break Apart FISH probe, to detect chromosomal rearrangements involving the TP63 gene. • 11q gain-loss FISH probe, to detect 11q Aberration. • ALK (2p23) Break Apart FISH probe, to detect chromosomal rearrangements involving the ALK gene on Chromosome 2p23. • ROS1 (6q22) Break Apart FISH probe, to detect chromosomal rearrangements involving the ROS1 gene on Chromosome 6q22. • MDM2/CEN12 Amplification FISH probe, to detect MDM2 gene amplification. • EWSR1 Break Apart FISH probe, to detect chromosomal rearrangements involving the EWSR1 gene. • MAML2 Break Apart FISH probe, to detect chromosomal rearrangements involving the MAML2 gene. • MYB Break Apart FISH probe, to detect chromosomal rearrangements involving the MYB gene. • FGFR2 Break Apart FISH probe, to detect chromosomal rearrangements involving the FGFR2 gene. • DAPI Counterstain The provider must be able to provide IVDR-certified probes in compliance with the Regulation for in vitro diagnostic medical devices (IVDR) for the diagnostic FISH service. Currently, the FISH technique is performed as a semi-automated assay on formalin-fixed, paraffin-embedded material. Therefore, the provider must be able to provide fluorescently labelled probes intended to be used on formalin-fixed, paraffin-embedded specimens in a ready to use format. Vendors must supply the different probe types used by the FISH service in SJH, ensuring reliable and reproducible results and long-term serviceability and user training. The provider must be able to provide IVDR-certified probes in compliance with the Regulation for in vitro diagnostic medical devices (IVDR) for the diagnostic FISH service. Vendors rs must supply the different probe types used by the FISH service in SJH, ensuring reliable and reproducible results and long-term serviceability and user training.

      Contact phone
      01 4162468
      Contact email
      dgunning@stjames.ie
      Address
      James Street, D08 NHY1 Dublin

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

    • Description

      price

    • Description

      quality

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    St James's Hospital
    Title
    Provision of fluorescently labelled probes for the Fluorescent in situ Hybridisation (FISH) Service in the Histopathology Dept at St James’s Hospital.
    Type
    ResultPrequalification
    Main code
    38000000Laboratory, optical and precision equipments (excl. glasses)
    Supplemental codes
    33696500Laboratory reagents
    Location
    Dublin
    Estimated value
    €1,500,000.00
    Duration
    60 months

    Active similar competitions

    • St James's Hospital

      Laboratorie- og analyseutstyr

      Invitation to tender for the provision of a Next Gen Sequencing Platform for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

      St James's Hospital needs a Next Gen Sequencing Platform for the Cancer Molecular Diagnostics Department in Dublin for 60 months, with a maximum total value of 1,850,000 EUR. BioSciences Limited a Thermo Fisher Company likely has a similar contract today.

      CompetitionSep 24, 2026
      Oct 29, 2026(19 days)
      €1,850,000
    • St James's Hospital

      Invitation to tender for the Provision of a Digital PCR Platform, Associated Reagents and Support for Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

      St James's Hospital needs a digital PCR platform, including all hardware, software, and ancillary equipment, along with associated reagents and support, for its Cancer Molecular Diagnostics Department in Dublin. The contract duration is 54 months, with a maximum total value of 250,000 EUR. The purchase includes a minimum three-year comprehensive warranty, installation, commissioning, and training. The platform will be used for assay development, evaluation, and method transfer, with an agreed quantity/value of development reagents and consumables to be drawn down over the three-year agreement.

      CompetitionOct 8, 2026
      Nov 10, 2026(31 days)
      €250,000
    • St James's Hospital

      Laboratorie- og analyseutstyr

      The Provision of a Coagulation Analytical Platform for the St James’s Hospital Coagulation Laboratory incorporating the National Centre for Hereditary Coagulation Disorders. at St James’s Hospital.

      St James's Hospital needs a coagulation analytical platform for the St James’s Hospital Coagulation Laboratory, incorporating the National Centre for Hereditary Coagulation Disorders, for 7 years, with a maximum total value of 4,550,000 EUR. The goods are to be delivered in Dublin, Ireland.

      CompetitionSep 23, 2026
      Oct 28, 2026(18 days)
      €4,550,000
    • Sykehusinnkjøp Hf

      Medisinsk og laboratorieutstyr

      NGS sekvenseringsplattform til avd. for patologi ved St. Olavs hospital HF

      Sykehusinnkjøp Hf planlegger anskaffelsen av en helautomatisert NGS-sekvenseringsplattform for avdeling for patologi ved St. Olavs hospital HF, som skal utvide og videreutvikle dagens analysekapasitet for klinisk diagnostikk av DNA og RNA fra FFPE-prøver og ctDNA. Løsningen skal være en samlet plattform som håndterer hele prosessen fra bibliotekspreparering til sekvensering, bioinformatisk analyse og rapportering, og skal være tilgjengelig med CE-IVD/IVDR-godkjente paneler der dette foreligger. Thermo Fisher Diagnostics AS har sannsynligvis kontrakten i dag.

      PlanningOct 8, 2026
      Feb 1, 2027(114 days)
      NOK 0
    • Oslo Universitetssykehus Hf

      Engroshandel med medisinske og husholdningsvarer

      78129 RH KLM IMM Produksjonsinstrument for celleterapi

      Oslo Universitetssykehus HF trenger et produksjonsinstrument for celleterapi, med opsjon på ytterligere ett instrument, programvare og forbruksmateriell, samt serviceavtaler, for en periode på 10 år. Instrumentet skal brukes til GMP-kompatibel sluttprosessering av celleterapiprodukter (ATMP), inkludert CAR-T-celler, ved Rikshospitalet i Oslo. Løsningen skal støtte en standardisert, automatisert og funksjonelt lukket arbeidsflyt for sluttprosessering, og bidra til redusert operatøravhengighet og kontaminasjonsrisiko. Miltenyi Biotech Norden AB har en lignende kontrakt i dag.

      CompetitionSep 21, 2026
      Oct 26, 2026(16 days)